Clinical Trials · NCT01509742
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 19
- Start date
- Apr 2001
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the Curve (AUC) glucagon